Hemostatic Disorders: all 514 studies

Page 1 of 6. Open to participants first (71), then studies with results posted, then the rest; newest registration first within each.

• The Safety of Simplified Tranexamic Acid RegimenRecruitingNCT07869537Phase 4
• Liver and Coagulation Disorders in Cardiac Transthyretin AmyloidosisRecruitingNCT07766135
• Harmony-HHT: ATV-1601 in Participants With Hereditary Hemorrhagic Telangiectasia (HHT)RecruitingNCT07601425Phase 1/2
• Effect of Ginger on Heavy Menstrual Bleeding in Women With Coagulation DisordersNot yet recruitingNCT07595640Early Phase 1
• ROTEM Interpretation AI vs ExpertsNot yet recruitingNCT07502950
• External Multicenter Validation of the APTTO Model for Prolonged APTT Using Clot Waveform AnalysisRecruitingNCT07418099
• Hemophilia A Research ProgramRecruitingNCT07414511
• Ex Vivo Reproduction of Minimally Invasive Surgery With Hematoma Lysis Using Modified Tissue Plasminogen Activator for Intracerebral HemorrhageRecruitingNCT07411079
• Association of Ultrasound Features of the Myometrium Suggestive of Adenomyosis and Clinical SymptomsRecruitingNCT07397715
• Study Protocol: Impact of Metamizole (Optalgin®) on Anti-Xa Concentrations in Oncology Patients Receiving DOACsRecruitingNCT07384013Not applicable
• Phase 3 Trial of Reltodecacog Alfa (VMX-C001) vs Usual Pharmacological Care in Patients Taking a FXa Direct Oral Anticoagulant Who Require Urgent Surgery With or Without Heparin.RecruitingNCT07288489Phase 3
• Sepsis-associated Thrombocytopenia and Platelet Transfusion （STAPT）RecruitingNCT07230067
• Phase IIb Multicenter Randomized Controlled Trial Evaluating the Efficacy of Sivelestat in Patients With Septic CoagulopathyNot yet recruitingNCT07214103Phase 2
• High-Altitude Hematology Observation-Stem Cell Transplantation (HALO-SCT)RecruitingNCT07205523
• Comparison of Heparin Anti-Xa Activity From Central Venous Catheter Samples Using a 5 mL Syringe Flush or a Vacuum Tube Flush Versus Peripheral Vein Samples in ICU PatientsRecruitingNCT07183605Not applicable
• Impact of IV Iron on Bleeding Symptoms in Iron Deficient Patients With Inherited Bleeding DisordersRecruitingNCT07083583
• A Study to Evaluate a Novel Gene Therapy in Patients With Relapsed and Refractory Multiple MyelomaRecruitingNCT07075185Phase 1
• Predictive Accuracy of PLR and PNR in Detecting ETICRecruitingNCT07046858
• The Impact of Nafamostat Mesylate on the Prognosis of Patients With Sepsis-Induced Coagulopathy Undergoing HemofiltrationNot yet recruitingNCT06994312Not applicable
• Detection of Bleeding Disorders Diagnosed After Vaginal Delivery Complicated by Severe Postpartum HemorrhageNot yet recruitingNCT06970860
• ROTEM in Sepsis Trauma Outcome in Intensive CareRecruitingNCT06891599
• Implementation of an Empiric Transfusion Bundle for Out of Hospital Patients With Haemorrhagic ShockRecruitingNCT06891131
• Patient Blood Management Implementation in CEE StudyRecruitingNCT06878105
• Prospective Observational Pilot Study of LMWH Versus UFH as ECMO Anticoagulation in Lung TransplantationRecruitingNCT06868823
• A Study to Learn About How Safe BAY 3389934 is, Its Suitable Dose, and How it Affects the Participants With Sepsis Induced CoagulopathyRecruitingNCT06854640Phase 1
• Viscoelastic Tests (VET) Versus Conventional Coagulation Tests (CCT) for Management of Trauma-Induced CoagulopathyNot yet recruitingNCT06820879Not applicable
• ATHNdataset RegistryRecruitingNCT06820515
• Hormonal Management of Heavy Menstrual Bleeding in AdolescentsRecruitingNCT06740929
• Tranexamic Acid in Patients With Traumatic Bleeding Based on Dynamic Monitoring of ThromboelastographyRecruitingNCT06736860Phase 4
• Early Genomic Testing for Inherited Bleeding DisordersRecruitingNCT06736158Early Phase 1
• Longitudinal Cohort of Thrombosis and Hemostasis DiseasesRecruitingNCT06727669
• Frequency, Predictors and Outcome of Sepsis Induced Coagulopathy in Critical Care UnitNot yet recruitingNCT06586346
• Evaluation of Clinical Ranges of Whole Blood Clotting Times of Patients on AnticoagulantsNot yet recruitingNCT06582563
• Pre-hospital Administration of Fibrinogen in Trauma-Induced CoagulopathyNot yet recruitingNCT06582420Not applicable
• Coagulation Disorders Secondary to Two Plasmapheresis Techniques (Double Filtration Plasmapheresis vs. PFS). Descriptive Pilot Study.RecruitingNCT06571552Not applicable
• SWIFT - SWIss Factor XIII Trial in PPHRecruitingNCT06481995Phase 4
• TRanEXamic Acid to Decrease Heavy Menstrual Bleeding in Individuals Anticoagulated for Venous Thromboembolism Pilot StudyNot yet recruitingNCT06452342Phase 4
• The Diagnostic and Prognostic Value of TAT, PIC, tPAI·C and TM in Sepsis-induced CoagulopathyNot yet recruitingNCT06379126
• A Study to Evaluate the Safety, PK/PD of (OriCAR-017) in Subjects With RR/MM - RIGEL StudyRecruitingNCT06271252Phase 1
• European Rare Blood Disorders Platform (ENROL)RecruitingNCT06250595
• Coagulopathy in Childhood Acute Lymphoblastic LeukaemiaNot yet recruitingNCT06242353
• Fibrinogen Concentrates Versus Cryoprecipitate in Liver Transplant SurgeryNot yet recruitingNCT06144112Phase 4
• Recombinant vWF Concentrate and ECMORecruitingNCT06118372Phase 1
• Nafamostat Mesilate in the Treatment of Severe Infection-associated CoagulopathyNot yet recruitingNCT06078839Phase 4
• The Impact of Coagulation Disorders on the Diagnosis and Prognosis of SepsisRecruitingNCT05998733
• Storytelling for Reducing Gap in Anticoagulation Use in African Americans With Atrial FibrillationEnrolling by invitationNCT05997914Not applicable
• The Incidence of Hyperfibrinolysis During Vaginal Delivery and Cesarean SectionRecruitingNCT05975112
• Caudal Analgesia & Anticoagulated PatientRecruitingNCT05946850
• Application of a New Type of Whole Blood Coagulation Time Measurement in Evaluating the Hypercoagulable State of Malignant TumorsRecruitingNCT05939960
• Heavy Menstrual Bleeding Progestin Treatment in Bleeding Disorders StudyRecruitingNCT05916469
• Validation of Point-of-care Thromboelastography (TEG 6s) in Pediatric PatientsRecruitingNCT05874843Not applicable
• Study of VGA039 in Healthy Volunteers and Patients With Von Willebrand Disease (VIVID)RecruitingNCT05776069Phase 1/2
• A Long-Term Follow-Up Study in Severe Hemophilia A Subjects Who Received BMN 270 in a Prior BioMarin Clinical Trial (270-401)Enrolling by invitationNCT05768386
• Bleeding of Unknown Cause: a Swiss Case-control StudyRecruitingNCT05713734
• Biomarkers and Prediction of Tigecycline Induced Coagulation DysfunctionNot yet recruitingNCT05698160
• Extracellular Vesicles and Dysregulated Coagulation in the Prediction of StrokeRecruitingNCT05645081
• To Evaluate Efficacy of Red Dichromatic Imaging (RDI) in Achieving Hemostasis During POEM Using GF 1500 UGI ScopeRecruitingNCT05476458
• A Study of TAK-330 to Reverse the Effects of Factor Xa Inhibitors For Adults Needing Urgent SurgeryRecruitingNCT05156983Phase 3
• The ENDOCARDITIS AUMC Data CollectionRecruitingNCT05139589
• Global Coagulation Assessment in Portal Vein Thrombosis and Budd-Chiari SyndromeRecruitingNCT05123326
• Blood Loss and PreeclampsiaRecruitingNCT04777097
• Bilateral Bi-level Erector Spine Plane Block as a Component of General Anesthesia in Surgical Correction of Spinal DeformationsRecruitingNCT04697498Not applicable
• Gyeongsang National University Hospital RegistryRecruitingNCT04650529
• National Longitudinal Cohort of Hematological DiseasesRecruitingNCT04645199
• The Utility of Thromboelastography in Traumatic Brain InjuryRecruitingNCT04524637
• ATHN Transcends: A Natural History Study of Non-Neoplastic Hematologic DisordersRecruitingNCT04398628
• Pharmacokinetics, Pharmacodynamics, and Safety Profile of Understudied Drugs Administered to Children Per Standard of Care (POPS)RecruitingNCT04278404
• World Bleeding Disorders RegistryRecruitingNCT03327779
• Dynamics of Platelet Activation in Patients With Ventricular Assist Device (VAD)RecruitingNCT03255928
• Swiss Hemophilia RegistryRecruitingNCT02512250
• Evaluation of Hemostasis in Bleeding and Thrombotic DisordersRecruitingNCT00178594
• A Study of Elranatamab (PF-06863135) in Chinese Participants With Refractory Multiple Myeloma.CompletedNCT05228470Phase 2Results posted
• RAS and Coagulopathy in COVID19CompletedNCT04419610Early Phase 1Results posted
• Coagulopathy of COVID-19: A Pragmatic Randomized Controlled Trial of Therapeutic Anticoagulation Versus Standard CareCompletedNCT04362085Phase 3Results posted
• Covid-19 Associated CoagulopathyCompletedNCT04360824Phase 4Results posted
• Study to Evaluate the Efficacy and Safety of Valoctocogene Roxaparvovec, With Prophylactic Steroids in Hemophilia ACompletedNCT04323098Phase 3Results posted
• XIENCE 28 USA StudyCompletedNCT03815175Not applicableResults posted
• A Pediatric Trial Using Tranexamic Acid in ThrombocytopeniaTerminatedNCT03806556Phase 1/2Results posted
• IV Ketorolac on Platelet Function Post-Cesarean DeliveryCompletedNCT03805607Phase 4Results posted
• Dose-finding Study of SPK-8016 Gene Therapy in Patients With Hemophilia A to Support Evaluation in Individuals With FVIII InhibitorsCompletedNCT03734588Phase 1/2Results posted
• Point-of-care Management of Coagulopathy in Lung TransplantationTerminatedNCT03598907Results posted
• A Research Study Looking at How a Factor VIII Medicine Called Turoctocog Alfa Pegol (N8-GP) Works in People With Haemophilia ACompletedNCT03528551Phase 3Results posted
• Gene Therapy Study in Severe Hemophilia A Patients With Antibodies Against AAV5TerminatedNCT03520712Phase 1/2Results posted
• Research Study to Look at Side Effects During Regular Injection With Factor VIII Medicine Named Turoctocog Alfa for a 8 Weeks PeriodCompletedNCT03449342Phase 4Results posted
• Adjusted Fibrinogen Replacement StrategyCompletedNCT03444324Phase 3Results posted
• XIENCE 28 Global StudyCompletedNCT03355742Not applicableResults posted
• Residual Anti-Xa Activity After Last Treatment Dose of EnoxaparinTerminatedNCT03296033Phase 4Results posted
• A Trial Evaluating the Efficacy and Safety of Prophylactic Administration of Concizumab in Haemophilia A and B Patients With InhibitorsCompletedNCT03196284Phase 2Results posted
• Efficacy and Safety of Turoctocog Alfa for Prophylaxis and Treatment of Bleeding Episodes in Previously Treated Chinese Patients With Haemophilia ACompletedNCT02938585Phase 3Results posted
• Human Fibrinogen Concentrate in Pediatric Cardiac SurgeryCompletedNCT02822599Phase 4Results posted
• Does Plasma Reduce Bleeding in Patients Undergoing Invasive ProceduresCompletedNCT02637427Phase 3Results posted
• Pharmacogenetic Testing of Saliva Samples From Patients With Five or More Exposure Days to rFVIIa Analogue in the Adept™2 TrialCompletedNCT02541942Phase 2Results posted
• Trial of RiaSTAP Versus Cryoprecipitate to Lower Operative TransfusionsTerminatedNCT02540434Not applicableResults posted
• Prospective Effect of Intravenous Ketorolac on Opioid Use, EBL and Complications Following Cesarean DeliveryCompletedNCT02509312Phase 4Results posted
• Comparison of Blood Product Use and Bleeding Events During and After Endoscopic or Neurosurgical Procedures in Patients With Cirrhosis and CoagulopathyCompletedNCT02457403Not applicableResults posted
• Short-term Cardiovascular Benefits of Wearing Particulate-filtering RespiratorsCompletedNCT02238028Not applicableResults posted
• Efficacy and Safety of Ledipasvir/Sofosbuvir Fixed-Dose Combination and Sofosbuvir + Ribavirin for Subjects With Chronic Hepatitis C Virus (HCV) and Inherited Bleeding DisordersCompletedNCT02120300Phase 2Results posted
• A Prospective Study of Airless Tubing in an Inpatient Acute Hemodialysis Unit in Hospitalized PatientsCompletedNCT02086682Results posted
• Effect of Antioxidant Vitamins on Coagulopathy and Nosocomial Pneumonia After Severe TraumaTerminatedNCT01897792Phase 2Results posted
• A Phase Ib/II Dose-finding Study to Assess the Safety and Efficacy of LDE225 + INC424 in Patients With MFCompletedNCT01787552Phase 1/2Results posted

← Hemostatic Disorders overview